Sean Eckley

732 total citations
7 papers, 139 citations indexed

About

Sean Eckley is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sean Eckley has authored 7 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Sean Eckley's work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Sean Eckley is often cited by papers focused on Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Sean Eckley collaborates with scholars based in United States, France and Germany. Sean Eckley's co-authors include Punit Marathe, Susanna Tse, Robert E. Fricke, Maciej J. Zamek‐Gliszczynski, Robert Chambers, Caroline A. Lee, Paul Harradine, J. Cory Kalvass, E.J. Perkins and Stacy Ho and has published in prestigious journals such as Blood, Cancer Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Sean Eckley

7 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean Eckley United States 5 72 50 22 22 17 7 139
Zhihong O’Brien United States 10 100 1.4× 39 0.8× 27 1.2× 32 1.5× 16 0.9× 12 226
Aarti Patel United Kingdom 7 44 0.6× 47 0.9× 18 0.8× 79 3.6× 19 1.1× 11 171
Akifumi Kogame Japan 9 186 2.6× 50 1.0× 21 1.0× 38 1.7× 18 1.1× 14 380
Min-Hwa Jasmine Lin United States 7 62 0.9× 68 1.4× 15 0.7× 66 3.0× 19 1.1× 11 159
Eric Garver United States 9 40 0.6× 50 1.0× 31 1.4× 24 1.1× 10 0.6× 10 186
Julie K. Rhie United States 9 54 0.8× 77 1.5× 15 0.7× 21 1.0× 4 0.2× 12 208
Naoya Matsumura Japan 11 81 1.1× 34 0.7× 14 0.6× 16 0.7× 17 1.0× 21 290
Patrick Flannery United States 9 88 1.2× 42 0.8× 23 1.0× 42 1.9× 6 0.4× 20 229
Sumit Punj United States 9 97 1.3× 30 0.6× 11 0.5× 7 0.3× 8 0.5× 16 248

Countries citing papers authored by Sean Eckley

Since Specialization
Citations

This map shows the geographic impact of Sean Eckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Eckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Eckley more than expected).

Fields of papers citing papers by Sean Eckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Eckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Eckley. The network helps show where Sean Eckley may publish in the future.

Co-authorship network of co-authors of Sean Eckley

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Eckley. A scholar is included among the top collaborators of Sean Eckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Eckley. Sean Eckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Alford, Joshua S., John W. Lampe, Richard Chesworth, et al.. (2022). Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies. ACS Medicinal Chemistry Letters. 13(7). 1137–1143. 16 indexed citations
2.
3.
Lampe, John W., Joshua S. Alford, Kenneth W. Duncan, et al.. (2021). Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. ACS Medicinal Chemistry Letters. 12(10). 1539–1545. 22 indexed citations
4.
Kolber‐Simonds, Donna, Jiayi Wu, Utpal Majumder, et al.. (2018). Abstract 3961: Role for neuropilin1 in mode of action of chlorotoxin. Cancer Research. 78(13_Supplement). 3961–3961. 1 indexed citations
5.
Di, Li, Robert Chambers, Sean Eckley, et al.. (2017). Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs. Journal of Pharmaceutical Sciences. 106(12). 3442–3452. 70 indexed citations
6.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo. Bioorganic & Medicinal Chemistry Letters. 21(6). 1634–1638. 12 indexed citations
7.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1639–1643. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026